In addition, inflammatory cytokines activate myostatin, which induces proteolytic phenotype muscle cells and inhibits satellite muscle cell proliferation, leading to skeletal muscle atrophy in CKD (Bataille et al., 2021). This evidence concerns the gene MSTN and chronic kidney disease.